|
Free
Strong beat and raised guidance meet rich multiples and heavy reinvestment cash drag.
|
Free
Oral GLP-1 and global filings signal a platform shift beyond injectable franchises.
|
Free
As Microsoft sends Halo to PlayStation, the traditional console war model gives way to ecosystem monetization.
|
Free
Higher prices and exclusivity shift could boost margins, but subscriber churn and competitive threats remain risks.
|
Free
China's biotech rise and local manufacturing now define global GLP-1 competitive advantage.
